1 Min Read
Nov 13 (Reuters) - Acer Therapeutics Inc:
* Acer Therapeutics reports third quarter 2017 financial results and provides corporate update
* Q3 loss per share $1.09 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.